Cancer research has seen advances in single-cell and spatial-omics technology and the heterogeneity within the tumour cells and their microenvironment is now elucidated at multi-dimensional levels. To ...

The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant ...

Although the concept of studying cells within the context of their location in tissues has been around for decades, the recent emergence of new technologies in spatial biology is ushering the field ...

Advancements to include CosMx® Whole Transcriptome Panel; enhanced technology engine to power CellScape™ for spatial proteomics; expansion to 1000-plex protein assay on GeoMx® DSP; and launch of ...

Spatial biology first entered the omics scene about a decade ago. Since then, the technology has generated significant buzz both inside and outside of the lab—beyond its contributions to science. The ...

Tissue function is shaped by a complex, multilayered molecular landscape, where even subtle disruptions in spatial organization can trigger – or indicate – the onset of disease. “Spatial biology ...

CHICAGO--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology and multiomics research at the 2025 American Association for ...

Developmental biology seeks to document the path from embryo to organism, where cell-to-cell interactions and the spatial organization of tissues influence developmental mechanisms. Consequently, ...

The Whole Transcriptome Panel for Bruker’s CosMx Spatial Molecular Imager (SMI) represents a breakthrough in spatial biology. With the ability to detect and quantify over 18,000 RNA transcripts at ...

Available later this quarter, the commercial CosMx SMI and AtoMx® SIP platforms will be upgraded to an integrated 2.0 software. Following this upgrade, commercial CosMx SMI instruments will deliver up ...